INTRODUCTION {#SEC1}
============

Yeasts are unicellular eukaryotic organisms with extraordinary diversity and properties. Many species have a strong impact in our way of life. For millennia, yeasts have played a crucial role in traditional biotechnology. In the past century, yeasts have become a crucial tool in modern biotechnology, serving as host for the production of added-value compounds, including recombinant proteins and primary and secondary metabolites. On the other hand, several yeast species have also been recognized as secondary pathogens in humans, being responsible for both superficial and deadly systemic infections.

*Saccharomyces cerevisiae* is a well-known eukaryotic model and was among the first to be used in biotechnological applications, that rendered it its street names 'baker\'s yeast' or 'brewer\'s yeast'. Many other yeast species were later used, or are being considered for use, as cell factories, often being selected for their unique properties. For example,the methylotrophic yeast *Komagataella phaffii* (formerly *Pichia pastoris*) is a well-established host for recombinant protein production that is being subjected to metabolic engineering to produce a diversity of bioproducts ([@B1],[@B2]); the food spoilage yeast *Zygosaccharomyces baillii* ([@B3],[@B4]) exhibits strong resistance to stress induced by weak organic acids food preservatives and, also for this reason, has been proposed as a cell factory for organic acids production; the Crabtree-negative species *Kluyveromyces lactis* is widely used in cheese production, given its ability to convert lactate into lactic acid and is attractive for the production of metabolites and heterologous proteins ([@B5]); the thermotolerant yeast *Kluyveromyces marxianus* is an established synthetic biology platform comparable to *S. cerevisiae* that hold potential for the industrial production of renewable chemicals ([@B6]); and *Yarrowia lipolytica* considered an oleaginous yeast, based on its ability to accumulate large amounts of lipids ([@B7]).

*Candida* species, on the other hand, are responsible for more than 400 000 life-threatening infections worldwide every year, being recognized as the fourth most common cause of nosocomial infections ([@B8]). More than 90% of all *Candida* infections are caused by *Candida albicans*, *Candida glabrata*, *Candida parapsilosis* and *Candida tropicalis*, with *C. albicans* being responsible for around half of all reported cases ([@B9]). These infections are typically associated to very high mortality rates ([@B10]), which are thought to be a consequence of the specific features associated to *Candida* pathogenesis.

The complete understanding of the molecular and regulatory mechanisms that control the productivity and stress resistance in biotechnologically relevant yeasts is key to guide the design of more effective cell factories. This includes, of course, understanding the transcriptional control of both biosynthetic and stress resistance pathways. For example, resistance to acetic acid is a crucial feature for many fermentative processes where acetic acid accumulates as by-product or is present as an inhibitor in the used raw materials, such as lignocellulosic hydrolysates. Moreover, acetic acid is a very common food preservative. Acetic acid tolerance in yeasts is tightly controlled at the transcriptional level by several transcription factors (TFs), particularly by Haa1, whose role in several yeast species, such as *S. cerevisiae* ([@B11],[@B12]), *Z. bailli* ([@B13]) and *C. glabrata* ([@B14]), has been documented.

The complete understanding of the molecular mechanisms that control pathogenesis-related phenotypes in these human pathogens is also key to guide the design of more effective therapeutic options. For example, the clinical evolution of *Candida* strains toward improved fitness, virulence or drug resistance is often the consequence of changes in TF activities. The most well-known of such cases is the acquisition of drug resistance mediated by gain-of-function mutations in the TF(s) that control the expression of drug efflux pumps capable of extruding azole drugs ([@B15]), namely Pdr1 from *C. glabrata* ([@B16]) and Tac1 from *C. albicans*, and *C. parapsilosis* ([@B17]).

In this release, YEASTRACT+ is presented as a portal that unites and integrates the previously existing YEASTRACT ([@B18]) and PathoYeastract ([@B23]) databases and the new NCYeastract (Non-Conventional Yeastract) database. Besides describing the updated versions of the YEASTRACT and PathoYeastract databases, in terms of the regulatory information gathered for *S. cerevisiae*, *C. albicans* and *C. glabrata*, it also presents upgrades in three directions: (i) two other Candida species were included in the PathoYeastract database, *C. parapsilosis* and *C. tropicalis*; (ii) the NCYeastract was developed, including five yeast species *Z. baillii*, *K. lactis*, *K. marxianus*, *Y. lipolytica* and *K. phaffii*; and (iii) further computational tools were added to the information system to increase the power of regulatory network visualizing tools and to improve the comparative genomics tools to enable cross-species comparison of regulatory networks and promoter sequences.

Data upgrade {#SEC1-1}
------------

In this paper, YEASTRACT+ is presented as a unified portal for the study of transcription regulation in yeasts. It includes updates on the YEASTRACT and PathoYeastract databases and the launching of the NCYeastract database, as detailed in the following paragraphs.

YEASTRACT was updated to include a total of 195 498 unique regulatory associations between TFs and target genes in *S. cerevisiae*, 20% more associations than in the previous version. It also includes 42 new TF binding sites, 16% more than before. Furthermore, the full data were revisited to populate the database with information that was missing on directionality (whether the TF is acting as repressor or activator in each association) or on environmental condition in which the transcriptional association was found to take place; this information was extended and now covers all TF--TG associations in YEASTRACT.

PathoYeastract was updated to gather all available information on transcriptional associations published in peer-reviewed international journals for *C. albicans* and *C. glabrata*. It now includes 35 687 and 3508 unique regulatory associations for these species, respectively, an update that represents a 50% increment on the available data. At least one target gene was found for 40 and 118 TFs, out of the 117 and 163 TF predicted to be encoded by the *C. albicans* and *C. glabrata* genomes, respectively. At last, 39 and 76 consensus sequences recognized as binding sites for 12 and 45 TFs in *C. albicans* and *C. glabrata*, respectively, are now deposited in the database. Furthermore, the database was expanded to include two more pathogenic yeasts, *C. parapsilosis* and *C. tropicalis*. As before, data on predicted protein orthology for these new species were retrieved from CGD, Candida Gene Order Browser (CGOB---<http://cgob.ucd.ie/>) ([@B24]) and associated Gene Ontology (GO) terms, and their corresponding hierarchy, were retrieved from the GO consortium database ([@B25]). Available data on these new species includes 698 unique associations between TF and target genes in *C. tropicalis*, and 6986 unique associations between TF and target genes in *C. parapsilosis*. At least one target gene was found for 16 and 11 TFs, out of the 131 and 145 TF predicted to be encoded by the *C. tropicalis* and *C. parapsilosis* genomes, respectively. Moreover, six consensus sequences were identified for a single TF, Efg1, in *C. parapsilosis*, while only one binding site was identified for one TF, Wor1, in *C. tropicalis*, in both cases based on bioinformatics predictions alone.

NCYeastract is the newest database in the YEASTRACT-PLUS portal. NCYeastract gathers currently all published regulatory associations and TF binding sites for five of the most relevant non-conventional (non-*Saccharomyces*) yeasts of biotechnological potential: *Z. baillii*, *K. lactis*, *K. marxianus*, *Y. lipolytica* and *K. phaffii*. 31, 126, 3, 9238 and 581 unique regulatory associations are currently available at NCYeastract, for each one of the referred species, respectively. Also 0, 2, 0, 1 and 0 TF binding sites, predicted for 1, 3, 0, 2 and 0 of the TFs in *Z. baillii*, *K. lactis*, *K. marxianus*, *Y. lipolytica* and *K. phaffii*, respectively, are included. Data on gene and promoter sequences and gene annotation for these five species were retrieved from the respective Genbank genome assembly, considering the following strains, respectively: IST302 ([@B26]), NRRL Y-1140, DMKU3-1042, CLIB122 and GS 115. GO was either annotated using the Blast2GO software ([@B27]) or retrieved from the fungal genomes browser Ensembl Fungi ([@B28]). Additionally, orthology associations between all the non-conventional yeast species added to the database and *S. cerevisiae* were inferred with the software OrthoFinder ([@B29]) and Proteinortho ([@B30]).

Altogether, YEASTRACT-PLUS gathers a total of 190 520 unique documented regulatory associations between TFs and target genes and 420 DNA binding sites, considering 247 TFs in the 10 yeast species. Also, more than 289 706 GO term associations to the genes gathered in the database.

All TF--target gene association or TF-consensus sequence association is automatically linked to specific information on the experimental setup used to identify it and to the environmental conditions in which that association was found to take place. The reference of the paper from which the information was retrieved, as well as the link to the corresponding PubMed page is always provided. The experimental basis of the associations between TFs and target genes is also included in the database. The underlying experimental evidence was collected and classified as either *DNA Binding* or *Expression Evidence*. *[DNA Binding Evidence]{.ul}* refers to experimental data obtained from chromatin immunoprecipitation (ChIP), ChIP-on-chip, ChIP-seq and electrophoretic mobility shift assay studies. *[Expression Evidence]{.ul}* refers to data obtained from the comparative analysis of gene expression changes occurring in response to the deletion, mutation or over-expression of a given TF, based on reverse transcriptase-polymerase chain reaction, microarray analysis, RNA sequencing or expression proteomics. Based on the gathered *Expression Evidence* each regulatory association was classified as positive or negative, considering TFs that act as activators or repressors in these conditions, respectively. Based on this classification, YEASTRACT+ contains a total of 45 209 regulatory associations based on DNA-binding evidence and 161 783 on expression evidence. Again, in all cases the environmental condition in which the regulatory association was found to occur was included in the database, and clustered into 14 groups, including: biofilm formation, carbon source quality/availability, cell cycle/morphology, complex industrial media, human niche conditions, *invitro*, ion/metal/phosphate/sulphur/vitamin availability, lipid supplementation, nitrogen source quality/availability, oxygen availability, pathogenicity, stress and unstressed log-phase growth (control). Each of these clusters is composed by sub-clusters to enable a finer filtering of the existing regulatory associations.

Improved tools for cross-species comparison {#SEC1-2}
-------------------------------------------

### Homologous network prediction {#SEC1-2-1}

There is a huge difference in the amount of available information for each of the yeast species currently hosted by YEASTRACT+. For example, considering the PathoYeastract data, there are 5- to 10-fold more regulatory associations gathered for *C. albicans* than for *C. parapsilosis* and *C. glabrata*, respectively, and this number jumps to more than 50-fold in comparison to *C. tropicalis*. But even *C. albicans*, which might be considered a well-studied organism, within the group of pathogenic yeasts, is relatively poorly known when compared to the model eukaryote *S. cerevisiae*, for which the YEASTRACT database gathers 547% more regulatory associations.

The lack of available data on some of the pathogenic yeasts hampers dramatically the current predictive power of a database such as PathoYeastract, unless the data gathered for better studied yeasts can be used to predict regulatory associations in less well studied species. With that aim, the possibility to predict the transcriptional control of a gene, or set of genes, based on the transcription of their orthologs in the remaining species is now offered in YEASTRACT+. To illustrate the usefulness of this tool, Figure [1](#F1){ref-type="fig"} represents the regulatory network that controls the 10 Drug:H+ Antiporters encoded in the *C. glabrata* genome, whose role in drug resistance has been well established in recent years ([@B15],[@B31]). This family of transporters include Aqr1, Dtr1, Flr1, Flr2, Qdr2, Tpo1_1, Tpo1_2, Tpo3 and two uncharacterized predicted drug transporters encoded by ORFs *CAGL0L10912g* and *CAGL0J00363g*. When using the 'Homologous network' tool to study the regulatory network controlling these 10 genes in *C. glabrata*, the obtained result shows that there are seven TFs involved in the control of eight of these genes, whose function is mostly related to drug resistance (Pdr1, Stb5 and Ada2) and stress response (Ap1, Haa1, Yap7 and Hal9). Interestingly, two of the selected genes, *CgAQR1* and *CgTPO1_2*, have no known regulators in *C. glabrata*. However, if the 'Network prediction' tool is used considering 'Search for homologous regulations in', the network of TFs predicted to control the same genes can be expanded to many other TFs, depending on the selected organism.

![Regulation of the Drug:H+ Antiporter genes from *Candida glabrata*, considering their known regulatory associations in *C. glabrata* or the regulation of their orthologs in *Candida albicans*, *Candida parapsilosis*, *Candida tropicalis* and *Saccharomyces cerevisiae*. The images were obtained using the 'Homologous network' tool, offered among the 'Cross species' queries. The experimental evidences underlying each regulatory association (in full lines, in the case of DNA-binding evidence, or in dashed lines in the case of expression evidence), as well as the sign of the interaction---positive (green), negative (red), positive and negative (brown) or undefined (black) are highlighted.](gkz859fig1){#F1}

For example, if the search is run against *C. albicans*, the network of TFs predicted to control the same genes increases to 29 TFs, some of which related to drug resistance (e.g. Tac1) and stress response (e.g. Cap1, Skn7 and Rim101), but others related to other interesting functions, such as carbon and nitrogen metabolism (Rgt1, Nrg1 and Met4) or biofilm formation (Tec1 and Snf5). These results are not just interesting in terms of their ability to expand the predicted network of TFs controlling a set of genes, but also suggest that these genes or their unexpected regulators may be involved in unforeseen biological processes. In this context, it is interesting to point out that at least one of the DHA transporters in *C. glabrata*, CgTpo1_2, is indeed required for biofilm formation ([@B34]), and others of the same family are suggested to do so as well, based on the TFs that control them.

### Network comparison {#SEC1-2-2}

Comparison of interspecies regulatory networks can be useful to identify functional elements without previous knowledge of function as well as identify significant evolutionary changes regarding transcriptional regulatory mechanisms. In YEASTRACT+, the user can now search for common and unique transcription regulatory associations of orthologous TFs in the 10 yeast species deposited therein, in a pairwise fashion, using the tool 'Network comparison'. To exemplify the exploitation of this new tool, the documented *Z. baillii* Haa1-regulon ([@B13]) was compared to those controlled by its two orthologs in *S. cerevisiae*, Haa1 ([@B12]) and Cup2 ([@B36]). Interestingly, the bi-functional *Z. baillii* Haa1 TF was found to play a dual role in the response to copper and to low-chain weak acid stress, functions that are fulfilled separately by its ortholog TFs Cup2 and Haa1, respectively, in *S. cerevisiae* ([@B13],[@B37]). The comparison between the ZbHaa1 and Haa1/Cup2 regulons, under acetic acid or copper stress, was carried out using this tool, leading to the definition of three regulatory networks for each stress condition, including the complete regulons of each TF and the core network found to be shared in the two species (Figure [2](#F2){ref-type="fig"}).

![Cross-species comparison of the ZbHaa1 versus ScHaa1/ScCup2 orthologous TF regulons, active under weak acid or metal stress, as obtained in the 'Network comparison' tool. The experimental evidences underlying each regulatory association (in full lines, in the case of DNA-binding evidence, or in dashed lines in the case of expression evidence), as well as the sign of the interaction---positive (green), negative (red), positive and negative (brown) or undefined (black) are highlighted.](gkz859fig2){#F2}

The results obtained show that the ZbHaa1- and Haa1-regulons in the response to acetic acid stress have two genes in common, *HSP26* and *YGP1*, which in *Z. bailii* correspond to three ORFs, *ZBIST_0079* (*HSP26*), *ZBIST_3442* (*HSP26_2*) and *ZBIST_0509* (*YGP1*). A similar approach can be used to compare the ZbHaa1 and Cup2 regulons under copper stress. In this case, the single shared target gene is *CRS5*, encoding a copper-binding metallothionein. These observations suggest that these stress responsive genes appear to be in the core of acetic acid or copper stress response in yeasts.

### Promoter analysis {#SEC1-2-3}

Promoter sequences are essential to the control of the expression of the downstream genes. Interestingly, it has been seen that promoter sequences suffer much faster evolution rates than coding sequences, except in specific regulatory regions ([@B38]). TF binding sites appear to be conserved to some extent, within phylogenetically related organisms ([@B38]), enabling the careful prediction of TF target genes in closely related species, based on the existence of predicted TF binding sites.

In this release of the YEASTRACT+ portal, a new 'Promoter Analysis' tool, for 'Cross species' comparison, is offered. In this tool, it is possible to search for the consensus sequences recognized by the TFs of a selected species in the promoter sequences of a given gene in one species, and in the promoters of all its orthologs in the remaining species deposited in the database. As an example, the promoters of the orthologs of the *C. albicans CDR1* gene from the four *Candida* species were compared to that of the *S. cerevisiae*, considering the TF binding sites described for *C. albicans* (Figure [3](#F3){ref-type="fig"}).

![Cross-species comparison of the promoters of the *CDR1* orthologous genes in *Candida* species and *Saccharomyces cerevisiae*, as obtained in the 'Promoter analysis' tool.](gkz859fig3){#F3}

First, it is highlighted that *C. glabrata* does not have a clear ortholog for this gene. As such, a 'No ortholog' message comes out. Second, this tool enables the search for TF consensus sequences that are present in all the promoters. The fact that nine TFs are predicted to bind to all these orthologous genes suggests that they are under a core conserved regulation. Additionally, there are specific TFs which are potential regulators of only one of these orthologous genes, for example, Upc2 and Sef1 in *C. parapsilosis*. This observation suggests that there might be some degree of specialization of this gene in each species, placing it under the control of alternative signaling pathways. Evidently, all hypotheses drawn through this analysis have to be considered only as indications that may guide further experimental work.

### Additional resources {#SEC1-2-4}

YEASTRACT+ continues to offer specific tools to enable its user to predict gene and genomic regulation. These predictions can be made either considering documented regulatory associations, those experimentally validated and published in peer-reviewed international journals, or potential regulatory associations, those based on the occurrence of TF consensus sequences in the promoter regions of the considered target genes. Additional filtering of the data can be carried out, by restricting the search to specific experimental data and/or specific environmental conditions. In the first case, the user can select only DNA-binding evidence of only expression evidence, or eventually only the regulatory associations for which there is simultaneous DNA binding and expression evidence. The filtering choice can produce quite different outcomes, as there are many cases of TFs for which the regulatory information based on DNA-binding or expression evidence can have little overlap, possibly due to lack of uniformity in the conducted experiments and to the fact that many genes whose expression is affected by a given TF, are not necessarily direct targets of this TF. For example, Figure [4](#F4){ref-type="fig"} illustrates this idea with the *C. parapsilosis* TF Efg1, involved in the control of concentric-to-smooth colony morphology switch and biofilm formation.

![The Efg1 regulon in *Candida parapsilosis* as obtained in the PathoYeastract database, considering different sources of experimental or predictive data. The image is obtained automatically, by accessing the Efg1 protein table, through the quick search tool, followed by selecting the 'See Venn diagram regulon' option.](gkz859fig4){#F4}

CpEfg1 affects the expression of 3213 genes, as detected mostly through genome-wide expression studies, and binds the promoter region of 2929 genes, as detected mostly through ChIP-seq analysis. However, only for 894 genes there is evidence of Efg1 both controlling their expression and binding to their promoter regions. Among this subset of Efg1 target genes, only 439 display Efg1 consensus binding sequences in their promoter regions. Altogether this example shows that there are much diversified sources of information on regulatory associations that need to be taken into account when using the tools made available at YEASTRACT+.

FUTURE DIRECTIONS {#SEC2}
=================

The YEASTRACT+ team is committed to continue to offer updated, reliable and complete information on the field of transcriptional regulation in yeasts to the international community working in the Biology and Biotechnology of yeasts, or on the molecular basis of candidaemia and its prophylaxis and treatment. Furthermore, the possibility to run a systematic inter-species comparison of transcription regulatory networks in different yeast will continue to be developed, especially through the development of more complex dedicated tools and the extension of the YEASTRACT+ databases to other relevant yeasts.

The YEASTRACT+ portal was constructed, in part, by joining the YEASTRACT (<http://yeastract.com>) and PathoYeastract (<http://pathoyeastract.org>) databases. All past and present colleagues and collaborators of the PathoYeastract and YEASTRACT projects are deeply acknowledged. The information about Candida and Saccharomyces genes other than documented regulations, potential regulations and the TF binding sites, were gathered from: Saccharomyces Genome Database (SGD), Candida Genome Database (CGD), Candida Gene Order Browser (CGOB) and GO Consortium. We acknowledge these four platforms for making that information available to the public in easily downloadable files.
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